Skip to content

Synovial Aspiration and Serological Testing in Two-stage Revision Arthroplasty of Prosthetic Joint Infection

Benefit of Synovial Aspiration and Serological Testing in Two-stage Revision Arthroplasty of Prosthetic Joint Infection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03038464
Acronym
SyPJI
Enrollment
40
Registered
2017-01-31
Start date
2016-11-01
Completion date
2019-05-01
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis Prosthetic Joint Infection

Brief summary

The two-stage protocol is gold standard in terms of infection control treating prosthetic joint infections of total hip and total knee arthroplasty. The antibiotic pause for diagnostic reasons before reconstruction (stage two) is discussed concerning persistence of infection and development of resistant bacterial strains. Serological markers and synovial analysis are common use to exclude persistence of infection. The investigators therefore asked 1) is the serological testing of c-reactive protein and leukocytes a valuable tool to predict a persistence of infection and 2) what is the role of synovial aspiration of PMMA Spacers on hip and knee joints.

Interventions

DIAGNOSTIC_TESTSynovial biopsy

Biopsy of jint prior reimplantation of new joint prosthesis

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with periprostheitc joint infection

Exclusion criteria

* Reinfection in history

Design outcomes

Primary

MeasureTime frameDescription
Reinfection rate2 yearsReinfection rate after reimplantation of joint prosthesis

Countries

Germany

Contacts

Primary Contactnorbert harrasser
norbert.harrasser@gmx.net15232716657

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026